Molecular model of the hepatitis C (HCV) drug simeprevir bound to its target viral enzyme. This antiviral drug, marketed as Olysio, is used to treat chronic hepatitis C infections. Simeprevir is a NS3-NS4A serine protease inhibitor. It prevents the virus from producing proteins that are essential for replication. The hepatitis C virus infects liver cells causing an inflammatory disease that can lead to degeneration and scarring (cirrhosis). Simeprevir is used in combination with the drugs peginterferon-alfa and ribavirin.

px px dpi = cm x cm = MB
Details

Creative#:

TOP14051995

Source:

達志影像

Authorization Type:

RM

Release Information:

須由TPG 完整授權

Model Release:

N/A

Property Release:

No

Right to Privacy:

No

Same folder images:

Same folder images